Tuesday, March 21, 2023
Schizophrenia is characterized by positive, negative, and cognitive symptoms. Evidence suggests functional impairments, which are predominantly associated with negative and cognitive symptoms, substantially interfere with work, school, and interpersonal relationships and are most distressing to patients, leading to a poor overall quality of life. Managing patients with schizophrenia requires assessing and treating all aspects of the disorder to achieve the goals of preventing relapse, increasing function to improve quality of life, and to facilitate re-integration into society.
Supported by an independent medical educational grant from
Intra-Cellular Therapies, Inc.
See All
See All
Steering Committee Chair
Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell, New York
Medical Director
Recognition and Prevention Program
Zucker Hillside Hospital
Glen Oaks, New York
Clinical Professor
Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York
Professor and Chairman
Department of Psychiatry
The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Hempstead, New York
Clinical Professor of Psychiatry
University of California, San Diego
La Jolla, California
Clinical Assistant Professor
School of Nursing
University of Texas at Austin
Austin, Texas
Professor and Chairman
Department of Psychiatry
Lou and Ellen McGinley Distinguished Chair in Psychiatric Research
McKenzie Chair in Psychiatry
University of Texas Southwestern Medical Center
Dallas, Texas
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Acadia; Alkermes; Allergan, Inc.; Angelini; Axsome; Gedeon Richter; Gerson Lehrman Group; Intra-Cellular Therapies; Janssen/J&J; LB Pharmaceuticals; Lundbeck Inc.; MedAvante-ProPhase; Neurocrine; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd; Recordati S.p.A; Rovi; Sumitomo Daimippon; Sunovion Pharmaceuticals, Inc.; Supernus; Takeda; Teva
Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Angelini; Gedeon Richter; Janssen/J&J; Lundbeck Inc.; Otsuka Pharmaceutical Co,; Pfizer Inc.; Recordati S.p.A; Sunovion Pharmaceuticals Inc.
Received grants for clinical research from: Janssen Pharmaceuticals; Takeda Pharmaceuticals North America, Inc.
Owns stock, stock options, or bonds from: LB Pharmaceuticals
Other: Data Safety Monitoring Board Chair for Lundbeck; Rovi; Supernus; Teva. Expert testimony for Janssen; Otsuka. Royalties from UpToDate
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Acadia; Alkermes; Allergan; Avanir; BioXcel; Eisai; Impel; Indivior; Intra-Cellular Therapies; Janssen; Lundbeck; Luye; Merck; Neurocrine; Noven; Osmotica; Otsuka; Pfizer; Sage; Shire; Sunovion; Takeda; Teva; Vanda
Served as a speaker or a member of a speakers bureau for: Acadia; Alkermes; Allergan; Janssen; Lundbeck; Merck; Neurocrine; Otsuka; Pfizer; Sage; Shire; Sunovion; Takeda; Teva
Owns stock, stock options, or bonds from: Bristol-Myers Squibb; Eli Lilly; J&J; Merck; Pfizer
Other: Elsevier; Springer Healthcare; UpToDate; Wiley
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alkermes, Allergan, Inc.; Dainippon Sumitomo Pharma America; H. Lundbeck A/S; Intracellular Therapies; Janssen Pharmaceutica; Johnson and Johnson; LB Pharmaceuticals, Inc.; Merck and Co., Inc.; Minerva Pharmaceutical; Neurocrine Biosciences, Inc.; Newron Pharmaceuticals S.p.A.; Otsuka Pharmaceutical Co., Ltd.; Pierre Fabre; Roche; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Received grants for clinical research from: Janssen Pharmaceuticals; Lundbeck, Incl; Otsuka Pharmaceutical Co., Ltd.
Owns stock, stock options, or bonds from: LB Pharma International B.V.; Vanguard Research Group
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: ACADIA Pharmaceuticals Inc.; Alkermes, Inc.; Allergan, Inc.; Intra-Cellular Therapies, Inc.; Neurocrine Biosciences, Inc.; Teva Pharmaceuticals USA
Served as a speaker or a member of a speakers bureau for: ACADIA Pharmaceuticals Inc.; Alkermes, Inc.; Allergan, Inc.; Intra-Cellular Therapies; Janssen Pharmaceutica; Neurocrine Biosciences, Inc.; Otsuka America, Inc.; Sunovion Pharmaceuticals Inc.; Teva Pharmaceuticals Industries, Ltd.
Steering Committee Member
Has disclosed no relevant financial relationships.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Astellas; Karuna; KyNexis; Sunovion